1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > World Generic Markets 02 MARCH 2015

World Generic Markets 02 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - Merck Provides MPP With Paediatric Raltegravir Licence
Industry Brief - Sucampo/R-Tech Settlement Overcomes Par Unoprostone ANDA
Industry Brief - Sandoz Launches Telmisartan In US
Industry Brief - Cambrex Expands Iowa API Facility
Industry Trend Analysis - Patent Ruling Edges Pulmicort Respules Toward Lifecycle End
Industry Brief - Teva Launches Enoxaparin And Linezolid Products In US
Industry Brief - Apotex' Second Biosimilar Application Accepted By FDA
Industry Brief - Actavis Gains US Buprenorphine Approval
Industry Brief - TWi To Sell Megestrol And Lidocaine Products In US
Industry Brief - Glenmark Launches Trandolapril+Verapamil In US
Industry Brief - Hospira Launches Inflectra In Remaining European Countries
Industry Brief - Use Of Biosimilar Infliximab Could Produce Significant CD Savings
Industry Brief - Acino Gains German Rivastigmine Court Victory
Industry Brief - Actavis To Divest Pharmatech To TPG
Industry Trend Analysis - Actavis' Future Dominated By Brands, But Generics Remain Important
Industry Brief - Actavis To Adopt Allergan Name
Industry Brief - Lupin And Celon Enter Fluticasone+Salmeterol Agreement
Industry Trend Analysis - Complex Sofosbuvir Relationship Favours Mylan
Industry Brief - Teva Commences USD1bn Debt Tender Offer

Table Of Contents

World Generic Markets 02 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Biosimilar Drug Market Research Report 2016

Global Biosimilar Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Biosimilar Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilar Drug industry, focusing on the main regions ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.